单细胞RNA测序揭示乳腺癌中异质性循环肿瘤细胞亚群
Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer.
作者信息
Papadaki Maria A, Agelaki Sofia
机构信息
Laboratory of Translational Oncology, School of Medicine, University of Crete, 70013 Heraklion, Greece.
Department of Medical Oncology, University General Hospital of Heraklion, 71110 Heraklion, Greece.
出版信息
Cancers (Basel). 2022 Mar 4;14(5):1314. doi: 10.3390/cancers14051314.
Abstract
Metastasis remains the main cause of death for breast cancer (BC) patients, and conceivably, a huge effort has been directed toward the understanding of the metastatic process [...].
摘要
转移仍然是乳腺癌（BC）患者死亡的主要原因，可以想象，人们已经付出了巨大努力来了解转移过程[……]。
相似文献
1
Single-Cell RNA Sequencing Uncovers Heterogeneous Circulating Tumor Cell Subsets in Breast Cancer.单细胞RNA测序揭示乳腺癌中异质性循环肿瘤细胞亚群
Cancers (Basel). 2022 Mar 4;14(5):1314. doi: 10.3390/cancers14051314.
2
Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.循环肿瘤细胞与循环癌症相关成纤维细胞的异型聚集促进乳腺癌转移。
Breast Cancer Res Treat. 2021 Aug;189(1):63-80. doi: 10.1007/s10549-021-06299-0. Epub 2021 Jul 3.
3
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds.循环肿瘤细胞在乳腺癌中的异质性：识别转移的种子。
Int J Mol Sci. 2020 Mar 2;21(5):1696. doi: 10.3390/ijms21051696.
4
De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.循环 miRNA 从头测序鉴定新的标志物预测局部晚期乳腺癌的临床预后。
J Transl Med. 2012 Mar 8;10:42. doi: 10.1186/1479-5876-10-42.
5
Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.循环 microRNA10b 基因表达及其靶标 E-钙黏蛋白作为乳腺癌预后和转移预测标志物的潜在价值。
J Clin Lab Anal. 2021 Aug;35(8):e23887. doi: 10.1002/jcla.23887. Epub 2021 Jul 15.
6
Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer.循环肿瘤细胞的代谢分类作为乳腺癌转移和预后的生物标志物。
J Transl Med. 2020 Feb 6;18(1):59. doi: 10.1186/s12967-020-02237-8.
7
The next generation personalized models to screen hidden layers of breast cancer tumorigenicity.下一代个性化模型筛选乳腺癌肿瘤发生的隐藏层。
Breast Cancer Res Treat. 2019 Jun;175(2):277-286. doi: 10.1007/s10549-019-05159-2. Epub 2019 Feb 27.
8
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer.在晚期乳腺癌的循环肿瘤细胞亚群中分析主要癌症基因变异。
Sci Rep. 2019 Nov 21;9(1):17276. doi: 10.1038/s41598-019-53660-x.
9
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.利用单细胞测序追踪乳腺癌中播散肿瘤细胞的起源
Genome Biol. 2016 Dec 9;17(1):250. doi: 10.1186/s13059-016-1109-7.
10
Circulating tumor cells in breast cancer beyond the genotype of primary tumor for tailored therapy.循环肿瘤细胞在乳腺癌中的作用超越了原发肿瘤的基因型，为个体化治疗提供了依据。
Int J Cancer. 2016 Apr 1;138(7):1586-600. doi: 10.1002/ijc.29679. Epub 2015 Jul 28.
引用本文的文献
1
Circulating Tumor Cells: How Far Have We Come with Mining These Seeds of Metastasis?循环肿瘤细胞：在挖掘这些转移种子方面我们已经取得了多大进展？
Cancers (Basel). 2024 Feb 17;16(4):816. doi: 10.3390/cancers16040816.
本文引用的文献
1
TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications.乳腺癌患者外周血中循环肿瘤细胞（CTC）和免疫细胞上的TLR4与pSTAT3表达：预后意义
Cancers (Basel). 2022 Feb 18;14(4):1053. doi: 10.3390/cancers14041053.
2
Transcriptomic profiling of single circulating tumor cells provides insight into human metastatic gastric cancer.单细胞循环肿瘤细胞的转录组谱分析为人类转移性胃癌提供了新见解。
Commun Biol. 2022 Jan 11;5(1):20. doi: 10.1038/s42003-021-02937-x.
3
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.循环肿瘤细胞转录组学作为转移性乳腺癌的活检替代物。
Ann Surg Oncol. 2022 May;29(5):2882-2894. doi: 10.1245/s10434-021-11135-2. Epub 2022 Jan 9.
4
Heterogeneity of Circulating Tumor Cell Neoplastic Subpopulations Outlined by Single-Cell Transcriptomics.单细胞转录组学勾勒出的循环肿瘤细胞肿瘤亚群的异质性
Cancers (Basel). 2021 Sep 29;13(19):4885. doi: 10.3390/cancers13194885.
5
Epithelial-to-mesenchymal Transition Heterogeneity of Circulating Tumor Cells and Their Correlation With MDSCs and Tregs in HER2-negative Metastatic Breast Cancer Patients.循环肿瘤细胞上皮-间充质转化异质性及其与 HER2 阴性转移性乳腺癌患者骨髓来源抑制性细胞和调节性 T 细胞的相关性。
Anticancer Res. 2021 Feb;41(2):661-670. doi: 10.21873/anticanres.14817.
6
Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome.接受艾瑞布林治疗的转移性乳腺癌患者循环肿瘤细胞中的上皮/间质特征及程序性死亡受体配体1共表达：与临床结局的相关性
Cancers (Basel). 2020 Dec 11;12(12):3735. doi: 10.3390/cancers12123735.
7
Optimization of the Enrichment of Circulating Tumor Cells for Downstream Phenotypic Analysis in Patients with Non-Small Cell Lung Cancer Treated with Anti-PD-1 Immunotherapy.非小细胞肺癌患者接受抗PD-1免疫治疗后循环肿瘤细胞富集的优化用于下游表型分析
Cancers (Basel). 2020 Jun 12;12(6):1556. doi: 10.3390/cancers12061556.
8
Tracking cancer progression: from circulating tumor cells to metastasis.追踪癌症进展：从循环肿瘤细胞到转移。
Genome Med. 2020 Mar 19;12(1):31. doi: 10.1186/s13073-020-00728-3.
9
Circulating Tumor Cells in Early and Advanced Breast Cancer; Biology and Prognostic Value.循环肿瘤细胞在早期和晚期乳腺癌中的生物学特征及预后价值。
Int J Mol Sci. 2020 Feb 29;21(5):1671. doi: 10.3390/ijms21051671.
10
Cancer transcriptomic profiling from rapidly enriched circulating tumor cells.从快速富集的循环肿瘤细胞中进行癌症转录组分析。
Int J Cancer. 2020 May 15;146(10):2845-2854. doi: 10.1002/ijc.32915. Epub 2020 Feb 27.
Zotero 插件